We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

212 hedge funds and large institutions have $2B invested in Ironwood Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 70 increasing their positions, 78 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

524% more call options, than puts

Call options by funds: $8.35M | Put options by funds: $1.34M

3.89% less ownership

Funds ownership: 108.92% → 105.03% (-3.9%)

7% less funds holding

Funds holding: 227 → 212 (-15)

10% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 78

14% less capital invested

Capital invested by funds: $2.31B → $2B (-$314M)

30% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 43

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
212
Holders Change
-15
Holders Change %
-6.61%
% of All Funds
3.26%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
30
Increased
70
Reduced
78
Closed
43
Calls
$8.35M
Puts
$1.34M
Net Calls
+$7.01M
Net Calls Change
-$3.26M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$23.3M
2
Norges Bank
Norges Bank
Norway
+$15.2M
3
ECM
ExodusPoint Capital Management
New York
+$6.99M
4
RA
Royce & Associates
New York
+$5.9M
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.76M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$30.7M
2
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
-$22.2M
3
PI
Putnam Investments
Massachusetts
-$17.3M
4
UBS AM
UBS AM
Illinois
-$12.1M
5
BCM
Brown Capital Management
Maryland
-$9.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
176
Ameritas Investment Partners
Nebraska
$133K – – –
PWPS
177
Pinnacle Wealth Planning Services
Ohio
$122K -$761 -62 -0.6%
CAN
178
Cetera Advisor Networks
California
$118K +$124K +10,128 New
FCI
179
Financial Counselors Inc
Kansas
$117K +$124K +10,070 New
Franklin Resources
180
Franklin Resources
California
$117K +$124K +10,098 New
Canada Life
181
Canada Life
Manitoba, Canada
$93K -$390K -31,773 -80%
Nisa Investment Advisors
182
Nisa Investment Advisors
Missouri
$79K -$14.8K -1,210 -15%
Fidelity Investments
183
Fidelity Investments
Massachusetts
$68K -$4.75K -387 -6%
SFM
184
Signet Financial Management
New Jersey
$31K +$32.4K +2,640 New
Northwestern Mutual Wealth Management
185
Northwestern Mutual Wealth Management
Wisconsin
$15K – – –
CAPTRUST Financial Advisors
186
CAPTRUST Financial Advisors
North Carolina
$13K +$4.83K +394 +56%
LPWM
187
Lake Point Wealth Management
Texas
$9K – – –
ACM
188
Aquatic Capital Management
Illinois
$9K +$9.81K +800 New
CYG
189
Clean Yield Group
Vermont
$8K – – –
ACM
190
Anfield Capital Management
California
$8K +$7.77K +633 +1,241%
NC
191
NewSquare Capital
Pennsylvania
$7K – – –
Daiwa Securities Group
192
Daiwa Securities Group
Japan
$6K -$982 -80 -14%
S
193
SignatureFD
Georgia
$5K – – –
WBC
194
West Branch Capital
Massachusetts
$5K – – –
C
195
Covestor
United Kingdom
$4K +$3.95K +322 New
SGAM
196
Smith Group Asset Management
Texas
$3K – – –
GWS
197
Glassman Wealth Services
Virginia
$2K -$184 -15 -8%
MAM
198
McCarthy Asset Management
California
$2K – – –
SCA
199
Snowden Capital Advisors
New York
$2K +$2.45K +200 New
VRS
200
Virginia Retirement Systems
Virginia
$1.74K -$713K -58,100 -28%
6 7
8
9 10

IRWD Hedge Fund Activity: Q4 2021 in Review

212 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2021, worth a combined $2B — down 14% from $2.31B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of IRWD and 30 opened new positions — a net loss of 13 holders — while 78 trimmed existing stakes and 70 added.

The largest buyer was BlackRock, adding an estimated $23.3M. The largest seller was Camber Capital Management, cutting an estimated $30.7M.

  • 212 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2021, down from 227 in Q3 2021.
  • Funds reported $2B of Ironwood Pharmaceuticals stock for Q4 2021, down 14% quarter-over-quarter.
  • 30 funds opened new Ironwood Pharmaceuticals positions in Q4 2021 and 43 closed out, a net change of -13 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q4 2021 was BlackRock, an estimated $23.3M added.
  • The largest Ironwood Pharmaceuticals seller in Q4 2021 was Camber Capital Management, an estimated $30.7M sold.

Based on aggregated 13F filings for Q4 2021.